Tackling Obesity During the COVID‐19 Pandemic
Amit Akirov,Avivit Cahn,Stefano Del Prato,Philip Home,Luc Van Gaal,Juliana Chan,Guang Ning,Itamar Raz
DOI: https://doi.org/10.1002/dmrr.3393
2020-01-01
Diabetes/Metabolism Research and Reviews
Abstract:Diabetes/Metabolism Research and ReviewsVolume 37, Issue 3 e3393 COMMENTARY Tackling obesity during the COVID-19 pandemic Amit Akirov, Amit Akirov orcid.org/0000-0002-9376-344X Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorAvivit Cahn, Corresponding Author Avivit Cahn [email protected] orcid.org/0000-0002-7830-9994 Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel Correspondence Avivit Cahn, Diabetes Unit, Endocrinology and Metabolism Unit, Hadassah Hebrew University Hospital, PO Box 12000, Jerusalem 91120, Israel. Email: [email protected]Search for more papers by this authorStefano Del Prato, Stefano Del Prato orcid.org/0000-0002-5388-0270 Department of Clinical & Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, ItalySearch for more papers by this authorPhilip Home, Philip Home orcid.org/0000-0001-5187-710X Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UKSearch for more papers by this authorLuc Van Gaal, Luc Van Gaal Department of Endocrinology & Metabolism, Antwerp University Hospital, Edegem-Antwerp, BelgiumSearch for more papers by this authorJuliana Chan, Juliana Chan Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China Li Ka Shing Institute of Health Science, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, ChinaSearch for more papers by this authorGuang Ning, Guang Ning Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorItamar Raz, Itamar Raz orcid.org/0000-0003-0209-4453 Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, IsraelSearch for more papers by this author on behalf of the Global CODHY Expert Forum Amit Akirov, Amit Akirov orcid.org/0000-0002-9376-344X Institute of Endocrinology, Beilinson Hospital, Petach Tikva, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this authorAvivit Cahn, Corresponding Author Avivit Cahn [email protected] orcid.org/0000-0002-7830-9994 Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel Correspondence Avivit Cahn, Diabetes Unit, Endocrinology and Metabolism Unit, Hadassah Hebrew University Hospital, PO Box 12000, Jerusalem 91120, Israel. Email: [email protected]Search for more papers by this authorStefano Del Prato, Stefano Del Prato orcid.org/0000-0002-5388-0270 Department of Clinical & Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, ItalySearch for more papers by this authorPhilip Home, Philip Home orcid.org/0000-0001-5187-710X Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UKSearch for more papers by this authorLuc Van Gaal, Luc Van Gaal Department of Endocrinology & Metabolism, Antwerp University Hospital, Edegem-Antwerp, BelgiumSearch for more papers by this authorJuliana Chan, Juliana Chan Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China Li Ka Shing Institute of Health Science, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, ChinaSearch for more papers by this authorGuang Ning, Guang Ning Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorItamar Raz, Itamar Raz orcid.org/0000-0003-0209-4453 Diabetes Unit, Department of Endocrinology and Metabolism, Faculty of Medicine, Hadassah Hebrew University Medical Center, Jerusalem, IsraelSearch for more papers by this author on behalf of the Global CODHY Expert Forum First published: 14 August 2020 https://doi.org/10.1002/dmrr.3393Citations: 2 Amit Akirov and Avivit Cahn contributed equally to this paper. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat CONFLICT OF INTEREST All authors have no conflict of interest relevant to this paper to declare. ETHICAL STATEMENT This is a review and not a study involving human or animal studies, therefore ethics approval was not required. AUTHOR CONTRIBUTION Amit Akirov and Avivit Cahn drafted the manuscript. All authors reviewed the manuscript, provided comments and expanded discussion and all authors approve the final submitted version. REFERENCES 1Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020; 323(13): 1239. http://dx.doi.org/10.1001/jama.2020.2648. 10.1001/jama.2020.2648 CASPubMedWeb of Science®Google Scholar 2Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062. 10.1016/S0140-6736(20)30566-3 CASPubMedWeb of Science®Google Scholar 3Zhang F, Xiong Y, Wei Y, et al. Obesity predisposes to the risk of higher mortality in young COVID-19 patients. J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26039. Web of Science®Google Scholar 4Gao F, Zheng KI, Wang X, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020; 43: e72-e74. 10.2337/dc20-0682 CASPubMedWeb of Science®Google Scholar 5Caussy C, Pattou F, Wallet F, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020; 8: 562-564. 10.1016/S2213-8587(20)30160-1 CASPubMedWeb of Science®Google Scholar 6Busetto L, Bettini S, Fabris R, et al. Obesity and COVID-19: an Italian snapshot. Obesity. 2020. http://dx.doi.org/10.1002/oby.22918. 10.1002/oby.22918 PubMedWeb of Science®Google Scholar 7Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab Syndr Clin Res Rev. 2020; 14: 655-659. 10.1016/j.dsx.2020.05.020 PubMedWeb of Science®Google Scholar 8Hajifathalian K, Kumar S, Newberry C, et al. Obesity is associated with worse outcomes in COVID-19: analysis of early data from New York city. Obesity. 2020. http://dx.doi.org/10.1002/oby.22923. 10.1002/oby.22923 PubMedWeb of Science®Google Scholar 9Simonnet A, Chetboun M, Possy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV- 2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020; 28: 1195-1199. 10.1002/oby.22831 CASPubMedWeb of Science®Google Scholar 10Drucker DJ. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev. 2020; 41: bnaa011. 10.1210/endrev/bnaa011 PubMedWeb of Science®Google Scholar 11Hales K, Carroll M, Fryar C, Ogden C. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;(360): 1-8. Google Scholar 12Rundle AG, Park Y, Herbstman JB, Kinsey EW, Wang YC. COVID-19–related school closings and risk of weight gain among children. Obesity. 2020; 28: 1008-1009. 10.1002/oby.22813 CASPubMedWeb of Science®Google Scholar 13Pellegrini M, Ponzo V, Rosato R, et al. Changes in weight and nutritional habits in adults with obesity during the "lockdown" period caused by the COVID-19 virus emergency. Nutrients. 2020; 12: 2016. 10.3390/nu12072016 CASPubMedWeb of Science®Google Scholar 14Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14; 917-920. 10.1016/j.dsx.2020.05.044 PubMedWeb of Science®Google Scholar 15He M, Xian Y, Lv X, He J, Ren Y. Changes in body weight, physical activity and lifestyle during the semi-lockdown period after the outbreak of COVID-19 in China: an online survey. Disaster Med Public Health Prep. 2020; 1-6. http://dx.doi.org/10.1017/dmp.2020.237. 10.1017/dmp.2020.237 Google Scholar 16Yates T, Razieh C. Obesity and risk of COVID-19: analysis of UK Biobank. Prim Care Diabetes. 2020, S1751-S991830196–0. 10.1016/j.pcd.2020.05.011 PubMedWeb of Science®Google Scholar 17Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020; 71(15): 896-897. http://dx.doi.org/10.1093/cid/ciaa415. 10.1093/cid/ciaa415 CASPubMedWeb of Science®Google Scholar 18Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020; 395: 1544-1545. 10.1016/S0140-6736(20)31024-2 CASPubMedWeb of Science®Google Scholar 19Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020; 63(8): 1500-1515. http://dx.doi.org/10.1007/s00125-020-05180-x. 10.1007/s00125-020-05180-x CASPubMedWeb of Science®Google Scholar 20Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020. http://dx.doi.org/10.1016/s2213-8587(20)30271-0. 10.1016/S2213-8587(20)30271-0 Web of Science®Google Scholar 21 OpenSAFELY Collaborative, Williamson E, Walker AJ, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020. Google Scholar 22Klok F, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145-147. 10.1016/j.thromres.2020.04.013 CASPubMedWeb of Science®Google Scholar 23Poyiadji N, Cormier P, Patel PY, et al. Acute pulmonary embolism and COVID-19. Radiology. 2020: 201955. http://dx.doi.org/10.1148/radiol.2020201955. 10.1148/radiol.2020201955 PubMedWeb of Science®Google Scholar 24Tibiriçá E, De Lorenzo A. Increased severity of COVID-19 in people with obesity: are we overlooking plausible biological mechanisms? Obesity. 2020; 28(8): 1374. http://dx.doi.org/10.1002/oby.22887. 10.1002/oby.22887 CASPubMedWeb of Science®Google Scholar 25Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417–1418. 10.1016/S0140-6736(20)30937-5 CASPubMedWeb of Science®Google Scholar 26Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020: 21: e13034. 10.1111/obr.13034 CASPubMedWeb of Science®Google Scholar 27Watanabe M, Risi R, Tuccinardi D, Baquero CJ, Manfrini S, Gnessi L. Obesity and SARS-CoV-2: a population to safeguard. Diabetes Metab Res Rev. 2020. http://dx.doi.org/10.1002/dmrr.3325. 10.1002/dmrr.3325 PubMedWeb of Science®Google Scholar 28Watanabe M, Caruso D, Tuccinardi D, et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. 2020; 154319. http://dx.doi.org/10.1016/j.metabol.2020.154319. 10.1016/j.metabol.2020.154319 PubMedWeb of Science®Google Scholar 29Kruglikov IL, & Scherer PE. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity. 2020; 28: 1187–1190. 10.1002/oby.22856 CASPubMedWeb of Science®Google Scholar 30Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019; 29: e2032. 10.1002/rmv.2032 PubMedWeb of Science®Google Scholar 31Mohamed-Hussein AAR, Aly KME, Ibrahim MEAA. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? Med Hypotheses. 2020; 144: 109975. 10.1016/j.mehy.2020.109975 CASPubMedWeb of Science®Google Scholar 32Ayerbe L, Risco C, Ayis S. The association between treatment with heparin and survival in patients with COVID-19. J Thromb Thrombolysis. 2020; 50(2): 298-301. http://dx.doi.org/10.1007/s11239-020-02162-z. 10.1007/s11239-020-02162-z CASPubMedWeb of Science®Google Scholar 33Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356: i6583. 10.1136/bmj.i6583 PubMedWeb of Science®Google Scholar 34Zhu L, She Z-G, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31: 30238–30242. 10.1016/j.cmet.2020.04.021 Web of Science®Google Scholar 35Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020; 164: 108214. http://dx.doi.org/10.1016/j.diabres.2020.108214. 10.1016/j.diabres.2020.108214 CASPubMedWeb of Science®Google Scholar 36Gao C, Cai Y, Zhang K, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. 2020; 41: 2058–2066. 10.1093/eurheartj/ehaa433 CASPubMedWeb of Science®Google Scholar 37Woo Baidal JA, Chang J, Hulse E, Turetsky R, Parkinson K, Rausch JC. Zooming toward a telehealth solution for vulnerable children with obesity during coronavirus 2019. Obesity. 2020; 28(7): 1184-1186. http://dx.doi.org/10.1002/oby.22860. 10.1002/oby.22860 CASPubMedWeb of Science®Google Scholar Citing Literature Volume37, Issue3March 2021e3393 This article also appears in:COVID-19 and Diabetes ReferencesRelatedInformation